SCHEMBL4715152

SCHEMBL4715152

O=[C]NCCCCCC1CCCCN1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.38
KMT2A Q03164 3/20 0.38
CYP2D6 P10635 2/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
TSHR P16473 1/20 0.38
MLNR O43193 1/20 0.38
ABCB11 O95342 1/20 0.38
EGFR P00533 1/20 0.38
FYN P06241 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
HTR1A P08908 1/20 0.38
CHRM5 P08912 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715155 0.79 HRH3 (0.39) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL24017137 0.78 SIGMAR1 (0.55) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL7294980 0.76 HRH3 (0.42) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL3029745 0.75 CYP2D6 (0.44) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL5258297 0.74 HRH3 (0.38) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL8860836 0.74 SIGMAR1 (0.58) SIGMAR1CYP1A2
SCHEMBL8861067 0.74 SIGMAR1 (0.58) SIGMAR1CYP1A2
SCHEMBL5663632 0.73 HRH3 (0.45) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL2090140 0.72 HRH3 (0.44) HRH3KMT2ACYP2D6MEN1LMNA
SCHEMBL7303522 0.72 S1PR1 (0.45) HRH3KMT2ACYP2D6MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed